Flow’s headset is the first tDCS device approved by the FDA ...

A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...

A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study. A device that delivers direct stimulation to ...

The U.S. Food and Drug Administration cleared Flow Neuroscience’s at-home electrical stimulation headset for adults with moderate-to-severe depression A trial of 174 people found the device led to ...

For the first time, Americans with depression will soon be able to use a prescription brain-stimulation device at home. The approval comes from the U.S. Food and Drug Administration and marks a major ...

The at-home brain stimulation device is expected to be available in the second quarter of 2026. The Food and Drug Administration (FDA) has cleared Flow, a prescription home-based cranial ...

A new study suggests that a promising noninvasive brain stimulation technique may not function exactly as psychiatrists had ...

Adding transcranial direct current stimulation (tDCS) to constraint-induced movement therapy (CIMT) after stroke offered no additional benefit in improving upper extremity function, new research ...

This story is part of a series on the current progression in Regenerative Medicine. This piece discusses advances in brain stimulation therapies. In 1999, I defined regenerative medicine as the ...